Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Pfizer Inc's subsidiary Hospira has secured an Indian patent for an improved process for the preparation of Cilastatin. Cilastatin is a chemical which acts with anti-biotic Imipenem for the treatment of infections in various body systems. Imipenem and Cilastatin are combined in a drug to make an anti-biotic.  It is used to treat serious infections that are mild to moderate in severity, such as lower respiratory infection and heart valve infection.

  • U.S. health regulators declined to approve a fixed-dose diabetes drug combination from AstraZeneca, delaying its launch and dealing a blow to an important plank of the drugmaker's business. Food and Drug Administration (FDA) stating that more clinical data were required before it could approve the combination of saxagliptin and dapagliflozin.

  • Male and female hearts change over time in significantly different ways, says a new study. The findings may shed light on different forms of heart failure seen in men and women that may require the development of gender-specific treatments, the scientists said.

  • Three days after Nestle India announced 100 percent safety clearance of Maggi noodle samples, the Gujarat government on Monday announced lifting of the ban on selling the popular food item, a top official said.

Subscribe to Pharma News